These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9269003)

  • 41. A medication monitor and fluorescein technique designed to study medication behaviour.
    Norell SE; Granström PA; Wassen R
    Acta Ophthalmol (Copenh); 1980 Jun; 58(3):459-67. PubMed ID: 7415831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled trial of an online educational video intervention to improve glaucoma eye drop technique.
    Davis SA; Carpenter DM; Blalock SJ; Budenz DL; Lee C; Muir KW; Robin AL; Sleath B
    Patient Educ Couns; 2019 May; 102(5):937-943. PubMed ID: 30583913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Administering eyedrops--no so simple at all].
    Berlepsch-Schreiner H; Glienke S; Staudacher D
    Krankenpfl Soins Infirm; 2014; 107(7):21-3. PubMed ID: 25090724
    [No Abstract]   [Full Text] [Related]  

  • 44. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients.
    Dietlein TS; Jordan JF; Lüke C; Schild A; Dinslage S; Krieglstein GK
    Acta Ophthalmol; 2008 Dec; 86(8):856-9. PubMed ID: 18494743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving eye drop adherence: a simple technique using a cable tie.
    Huang S; Andrew N
    Acta Ophthalmol; 2020 May; 98(3):e396. PubMed ID: 31686428
    [No Abstract]   [Full Text] [Related]  

  • 46. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of topical instillation technique in Japanese glaucoma patients.
    Ikeda H; Tsukamoto H; Sugimoto A; Sawa A; Crabtree BL; Byrd HJ; Murakami T; Mishima HK; Kihira K
    Pharmazie; 2008 Jan; 63(1):81-5. PubMed ID: 18271310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Instilling eyedrops: difficulties experienced by patients following cataract surgery.
    Donnelly D
    J Adv Nurs; 1987 Mar; 12(2):235-43. PubMed ID: 3646277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ways to improve ocular bioavailability for topical applications].
    Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
    J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Issues in the use of preservative-free topicals.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of eyedrop instillation technique with and without a delivery device in inexperienced patients.
    Gomes BF; Lordello M; Celli LF; Santhiago MR; Moraes HV
    Eur J Ophthalmol; 2016 Nov; 26(6):594-597. PubMed ID: 27135092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eye drop compliance in religious fasting.
    Moradi P
    Ophthalmology; 2008 Aug; 115(8):1440; author reply 1440-1. PubMed ID: 18675710
    [No Abstract]   [Full Text] [Related]  

  • 54. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Daily cost of ophthalmic solutions used to treat allergic conjunctivitis in Japan.
    Ikeda H; Tsukamoto H; Sato E; Mishima HK; Kihira K
    Ophthalmic Epidemiol; 2004 Feb; 11(1):35-42. PubMed ID: 14977495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open drops in ophthalmology offices: expiration and contamination.
    Wessels IF; Bekendam P; Calvin WS; Zimmerman GJ
    Ophthalmic Surg Lasers; 1999; 30(7):540-6. PubMed ID: 10929977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why are physicians not persuaded by scientific evidence? A grounded theory interview study.
    Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O
    BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eye drop technique and patient-reported problems in a real-world population of eye drop users.
    Mehuys E; Delaey C; Christiaens T; Van Bortel L; Van Tongelen I; Remon JP; Boussery K
    Eye (Lond); 2020 Aug; 34(8):1392-1398. PubMed ID: 31690823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methods for self-administration of eyedrops.
    Letocha CE
    Ann Ophthalmol; 1985 Dec; 17(12):768-9. PubMed ID: 4091376
    [No Abstract]   [Full Text] [Related]  

  • 60. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.